Biochemistry

Vision Statement

Vision Statement:
The Department of Biochemistry, AIIMS Bilaspur, established in 2020, envisions becoming a premier center of excellence in education, research, and clinical diagnostics.

Mission Statement

Mission Statement:

  • To establish an exemplary department that excels in providing high-quality education for both undergraduate and postgraduate students.
  • To develop a state-of-the-art hospital laboratory as per national and international standards, ensuring the delivery of accurate and reliable test results.
  • To make substantial contributions to the advancement of medical science by nurturing a collaborative research environment.

Faculty

S. No. Photo Name & Qualification Designation Areas of Interest Email ID / Research-gate Page
1   Dr. Sadhna Sharma Professor   dr.sadhna.biochem@aiimsbilaspur.edu.in
2 Dr. Sumita Sharma Dr. Sumita Sharma; M.D. Additional Professor & Head Quality control in clinical laboratory, Newborn screening, Haemoglobinopathies, Biomarkers of lifestyle related diseases dr.sumita.biochem@aiimsbilaspur.edu.in
3 Dr. Deepti Malik Dr. Deepti Malik; Ph.D. Associate Professor Haematological malignancies, Oncology, Molecular Diagnostics dr.deepti.biochem@aiimsbilaspur.edu.in
4 Dr. Anurag Sankhyan Dr. Anurag Sankhyan; Ph.D. Associate Professor Antibody & protein engineering for molecular diagnostics and bio-therapeutics; Gut & liver pathogens, cancer and toxins; Metabolic disorders dr.anurag.biochem@aiimsbilaspur.edu.in
5 Dr. Sanjukta Naik Dr. Sanjukta Naik; M.D. Assistant Professor Nutrigenomics, Newborn screening, Flow cytometry, Fertility markers dr.sanjukta.biochem@aiimsbilaspur.edu.in
6 Dr. Anudeep P P Dr. Anudeep P P; M.D. Assistant Professor Metabolic and nutritional disorders, Medical Education dr.anudeep.biochem@aiimsbilaspur.edu.in

Expansion Plan

S. No. Collaboration for Collaboration with Department and Institute Services Offered / Work Undergoing in Collaboration
1 Newborn Screening Services Clinical departments especially Neonatology, Paediatrics, Obstetrics and Gynaecology Planned initiation of newborn screening services for institutional deliveries, with phased expansion to other state medical colleges and regional hospitals. The proposed panel includes thyroid-stimulating hormone, 17-hydroxyprogesterone, biotinidase activity, G6PD activity and total galactose.
2 Maternal / Prenatal Screening Markers Clinical departments especially Obstetrics and Gynaecology Planned initiation of maternal/prenatal screening markers, including dual test and other relevant antenatal screening investigations.
3 Protein Electrophoresis and Immunotyping Services Various clinical departments Planned initiation of protein electrophoresis services for diagnostic evaluation of monoclonal gammopathies, chronic inflammatory states and other clinically indicated conditions.
4 Expansion of Routine and Immunoassay-Based Investigations Various clinical departments Expansion of routine biochemical and immunoassay-based diagnostic investigations to strengthen patient care, clinical decision-making and institutional diagnostic capacity.

Services

In-patients department 

Outpatients department 

Procedures Diagnostic and/or Therapeutic) offered by the department: 

Diagnostic services offered by the Department: 

Routine Biochemistry Services 

 • Renal Function Test (Urea, Creatinine, Uric acid, Calcium, Phosphorus)
 • Liver Function Test (Total Bilirubin, Direct Bilirubin, SGOT/AST, SGPT/ALT, Alkaline Phosphatase (ALP), Total Protein,       Albumin, Globulin, A:G Ratio)
 • Electrolytes (Sodium, Potassium, Chloride)
 • Pleural/Peritoneal/Pericardial Fluid analysis (Glucose, Protein, Albumin, LDH, ADA)
 • Cerebrospinal Fluid (CSF) analysis (Glucose, Protein, Albumin, LDH, ADA)
 • Urinary parameters: Microalbumin/ACR (Albumin Creatinine ratio), Urinary spot protein: creatinine ratio, 24 hrs  Urinary protein, Urinary Urea-spot and 24 hrs, Urinary creatinine-spot and 24 hrs, Urinary uric acid-spot and 24 hrs,  Urinary calcium-spot and 24 hrs, Urinary phosphorous-spot and 24 hrs, Urinary sodium-spot and 24 hrs, Urinary  potassium-spot and 24 hrs
 • Iron profile: Iron, TIBC, Ferritin
 • Rheumatoid Factor
 • Blood ammonia levels
 • Serum and urine osmolality
 • HPLC for haemoglobinopathies and HbA1C

Immunodiagnostic Services

 • Hormone tests: Thyroid function tests (T3, T4, FT3, FT4, TSH, Anti TPO), Parathyroid hormone (iPTH), Fertility profile  (FSH, LH, Prolactin), Testosterone, Insulin, Cortisol, c-peptide
 • Tumour markers – CEA, CA 19.9, CA125, CA 15.3, Total PSA, AFP, beta hCG
 • Nutritional assays - Vitamin D, Vitamin B12, Folate, Ferritin
 • Cardiac markers: NT Pro BNP, hsTroponin T
 • ELISA Investigations: Anti CCP, Anti tTG-IgA, Beta 2 Microglobulin

Molecular Diagnostic Services

 • Deletion study for Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD)
 • DNA based mutation detection in Thalassemia (beta-thalassemia)
 • JAK V617F mutation.

Statistics Courses & Short term Trainings

S. No. Name of the Course Duration of Course Present Number of Students Objectives / Brief Description of the Course

Projects

S.No Title Principal Investigator Co-Investigator Collaboration if any (Department and Institute) Funding Agency Project Status
1 Sigma Metrics: An Essential Tool for Performance Evaluation and Quality Control in Clinical Biochemistry Laboratory Dr. Anupam Parashar Dr. Sumita Sharma Dr. Anurag Sankhyan Self- Funded Completed
2 Assessment of association of lifestyle-related disease biomarkers with autonomic and cognitive functions in different age group natives of Spiti Valley of Himachal Pradesh: A comprehensive observational cross sectional study   Dr. Sumita Sharma   ICMR Ongoing
3 Estimate the prevalence of Iodine deficiency and investigate the association between iodine and selenium status with thyroid function and thyroid autoimmunity during pregnancy in a tribal area of Himachal Pradesh   Dr. Sumita Sharma   DHR Ongoing
4 Prevalence and associated characteristics of Latent Autoimmune Diabetes in Adults-A hospital-based study   Dr. Sumita Sharma   Self-funded Ongoing
5 Determinants of Severity and Length of Hospital Stay in Hospitalized Leptospirosis Patients in a Tertiary Care Setting: A Retrospective Observational Study   Dr. Sumita Sharma   Self-funded Ongoing
6 Assessment of Thyroid Functions, Urinary Iodine, and Antithyroid Peroxidase Antibody Status Among the Tribal Population of Himachal Pradesh: A Cross-sectional study   Dr. Sumita Sharma   Ministry of Tribal Affairs Ongoing
7 Holistic Lifestyle Intervention (Structured vs. Routine Care) in Adolescent Females with PCOS: A Randomized Control Trial   Dr. Sumita Sharma   ICMR Approved
8 To illustrate how miR- 2909 RNomics governs TGFb signalling cascade in Human Prostate Cancer Dr Deepti Malik   The proposed study is collaborative study between AIIMS, Bilaspur and PGIMER Chandigarh ICMR Ongoing
9 Mutation-Analysis of beta-Thalassemia in Patients at Tertiary Care Hospital Dr Deepti Malik     AIIMS Bilaspur IEC Pending
10 Clinico-metabolic profile of PCOS in the SubHimalayan region of North India- A prospective Study   Dr Deepti Malik   CSR Completed
11 Development of new recombinant polyvalent antivenom targeting multifunctional toxins of the ‘big four’ Indian snakes. Dr. Anurag Sankhyan     ICMR Ongoing
12 The study of novel serum biomarker soluble fmslike tyrosine kinase-1/ placental growth factor for early prediction of pre-eclampsia   Dr. Anurag Sankhyan The study is a collaborative study between AIIMS Bilaspur, HP and PGIMER, Chandigarh DHR Ongoing
13 Estimation of pancreatic fat fraction in individuals with diabetes, prediabetes and healthy controls and its correlation with indices   Dr. Anurag Sankhyan   ESI Ongoing
14 Unravelling the Significance of FAT1-Regulated Microprotein miPEP133 in Glioma Aggressiveness   Dr. Anurag Sankhyan The study is a collaborative study between Co-PI at Dept. of Biochemistry, AIIMS Bilaspur, HP and PI at Dept. of Biochemistry, AIIMS New Delhi LTMT Ongoing
15 Assessment of Vitamin D and Vitamin B12 status in T2DM patients taking either metformin or combination of metformin + DPP-4 inhibitor - Retrospective study. Dr. Anurag Sankhyan     CMR Ongoing
16 The role of miRNA200 family (miRNA 200a, miRNA200b, miRNA 200c, miRNA141, miRNA 429) in epithelial ovarian cancer   Dr. Anurag Sankhyan   AIIMS Bilaspur Ongoing